Viva Biotech’s Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection
SHANGHAI, March 28, 2025 /PRNewswire/ -- Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ("Viva Biotech"), underwent a cGMP (Current Good Manufacturing Practices) on-site inspection by the U.S. Food and Drug Administration ("FDA"), and received the EIR (Establishment Inspection Report) from the FDA. This is the fourth time that Langhua Pharmaceutical has undergone...
IASO Bio Announces Approval of New Drug Application for Equecabtagene Autoleucel by the Macau Pharmaceutical Administration Bureau
SHANGHAI, NANJING, China and SAN JOSE, Calif., March 28, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that the Pharmaceutical Administration Bureau of the Macao Special Administrative Region (ISAF) has approved the New Drug Application (NDA) for Equecabtagene Autoleucel. This treatment is...
Fangzhou Inc. Named Among Guangzhou’s Top AI Innovators for Intelligent Healthcare Platform
GUANGZHOU, China, March 28, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, has been named to the 2024 Guangzhou Artificial Intelligence Innovation Development List as "Most Promising Enterprise," while its H2H Smart Healthcare Ecosystem secured a spot on the "Application Scenario Innovation List" as...
Neutech Group Limited Announces 2024 Annual Results
Deepening the Strategic Transformation toward an Ecosystem of Education, Healthcare, Wellness, and Mind Tour, with Synergies Increasingly Materializing HONG KONG, March 28, 2025 /PRNewswire/ -- On the evening of March 27th, 2025, Neutech Group Limited (Stock Code: 9616.HK) announced the annual results of 2024. In 2024, the Group leveraged the "Education + Technology + Services" tri-engine model and pursued integrated development across...
Wai Yuen Tong leads the digitalization of traditional Chinese medicine introducing Hong Kong’s first smart AI constitution analysis device, pioneers Hong Kong into a new era of healthcare in...
HONG KONG, March 28, 2025 /PRNewswire/ -- Wai Yuen Tong (0897.HK), a pioneer in traditional Chinese medicine in Hong Kong, announced that starting today, five core stores located in Percival Street Causeway Bay, Nathan Road Mong Kok, Cameron Road Tsim Sha Tsui, New Town Plaza Sha Tin, and Telford Plaza Kowloon Bay will initiate a trial introduction of the...
Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients
SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., March 28, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced topline data of a Phase 2b study in refractory gout patients with its investigational drug...
AAHRPP Accredits Two More International Organizations, Including the First in United Arab Emirates
WASHINGTON, March 27, 2025 /PRNewswire/ -- The Association for the Accreditation of Human Research Protection Programs has accredited two more international organizations: Academia Sinica in Taiwan and Cleveland Clinic Abu Dhabi in United Arab Emirates—the first UAE research organization to earn the AAHRPP "gold seal." The newly accredited organizations join 600 entities...
TraceLink Secures Top Honors with BSMA Supply Chain Excellence Award for Multienterprise Information Network Tower (MINT) Innovation
BOSTON, March 28, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has been named a winner of the 2025 BSMA Supply Chain Management Innovation Award for its Multienterprise Information Network Tower (MINT) solution. The BSMA Supply Chain Management Innovation Award recognizes outstanding...
Getinge publishes Annual Report for 2024
GOTHENBURG, Sweden, March 27, 2025 /PRNewswire/ -- Today, Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes a year characterized by strong growth, increased customer satisfaction, and successful product launches. The global medtech company has reached new sales records, strengthened its acquisitions, and continued to develop innovative solutions that improve healthcare - all while maintaining...
Viva Biotech Announces 2024 Annual Results: Significantly Rebounding in Performance with New Stage ahead, AI Leads to a New Era of Novel Drug R&D
Highlights of Annual Results for the Year Ended December 31, 2024Revenue reached RMB1,986.7 millionGross profit amounted to RMB687.4 millionNet profit recorded RMB222.0 million, a significant turnaround from a year agoAdjusted Non-IFRS net profit recorded RMB314.6 million, a YOY increase of nearly 50.6%. SHANGHAI, March 27, 2025 /PRNewswire/ -- On March 27, 2025, Viva Biotech Holdings ("Viva Biotech", "the Group"...
